Staphylococcus aureus fluorescence detection method based on navigation type DNA walker and fluorescence regulation mechanism
By constructing a navigation-type DNA walker and a fluorescence regulation mechanism, and utilizing a dual-enzyme recognition reaction system of exonucleases I and III, a highly efficient quantitative detection of Staphylococcus aureus was achieved. This solved the problems of random movement and low sensitivity of traditional DNA walkers, and improved the accuracy and sensitivity of the detection.
CN116334258BActive Publication Date: 2026-05-12NANTONG KINGHUNT BIOLOGY TECH DEV CO LTD
View PDF 3 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANTONG KINGHUNT BIOLOGY TECH DEV CO LTD
- Filing Date
- 2023-03-06
- Publication Date
- 2026-05-12
Smart Images

Figure CN116334258B_ABST
Abstract
This invention relates to a fluorescence detection method for Staphylococcus aureus based on a navigation-type DNA walker and a fluorescence regulation mechanism. It utilizes a dual-enzyme recognition reaction system of exonuclease I and exonuclease III to identify and distinguish samples containing / without Staphylococcus aureus. Samples containing Staphylococcus aureus generate an efficient fuel chain in the dual-enzyme recognition reaction system, causing the DNA walker to shift along its trajectory, further triggering fluorescence resonance energy transfer, ultimately obtaining an amplified fluorescence signal correlated with the target concentration. The concentration of Staphylococcus aureus in the contaminated sample is determined based on the relationship between fluorescence intensity and Staphylococcus aureus concentration. This invention improves the controllability and efficiency of the DNA walker, reducing the risk of derailment and interruption. The detection range is 9-90 CFU / mL. ‑1 Within its detection range, the accuracy of quantitative detection reaches 100%, and the reproducibility and recovery rate exceed 98%, capable of detecting substances containing 2 CFU / mL. ‑1 The sample of Staphylococcus aureus.
Need to check novelty before this filing date? Find Prior Art